291 related articles for article (PubMed ID: 31028100)
1. TET enzymes augment activation-induced deaminase (AID) expression via 5-hydroxymethylcytosine modifications at the
Lio CJ; Shukla V; Samaniego-Castruita D; González-Avalos E; Chakraborty A; Yue X; Schatz DG; Ay F; Rao A
Sci Immunol; 2019 Apr; 4(34):. PubMed ID: 31028100
[TBL] [Abstract][Full Text] [Related]
2. TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells.
Schoeler K; Aufschnaiter A; Messner S; Derudder E; Herzog S; Villunger A; Rajewsky K; Labi V
FEBS J; 2019 Sep; 286(18):3566-3581. PubMed ID: 31120187
[TBL] [Abstract][Full Text] [Related]
3. Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.
Adam S; Bräcker J; Klingel V; Osteresch B; Radde NE; Brockmeyer J; Bashtrykov P; Jeltsch A
Commun Biol; 2022 Jan; 5(1):92. PubMed ID: 35075236
[TBL] [Abstract][Full Text] [Related]
4. BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice.
Morman RE; Schweickert PG; Konieczny SF; Taparowsky EJ
Eur J Immunol; 2018 Sep; 48(9):1492-1505. PubMed ID: 29898247
[TBL] [Abstract][Full Text] [Related]
5. Tet2 and Tet3 cooperate with B-lineage transcription factors to regulate DNA modification and chromatin accessibility.
Lio CW; Zhang J; González-Avalos E; Hogan PG; Chang X; Rao A
Elife; 2016 Nov; 5():. PubMed ID: 27869616
[TBL] [Abstract][Full Text] [Related]
6. The transcription factor BATF controls the global regulators of class-switch recombination in both B cells and T cells.
Ise W; Kohyama M; Schraml BU; Zhang T; Schwer B; Basu U; Alt FW; Tang J; Oltz EM; Murphy TL; Murphy KM
Nat Immunol; 2011 Jun; 12(6):536-43. PubMed ID: 21572431
[TBL] [Abstract][Full Text] [Related]
7. Functionally distinct roles for TET-oxidized 5-methylcytosine bases in somatic reprogramming to pluripotency.
Caldwell BA; Liu MY; Prasasya RD; Wang T; DeNizio JE; Leu NA; Amoh NYA; Krapp C; Lan Y; Shields EJ; Bonasio R; Lengner CJ; Kohli RM; Bartolomei MS
Mol Cell; 2021 Feb; 81(4):859-869.e8. PubMed ID: 33352108
[TBL] [Abstract][Full Text] [Related]
8. TET Enzymes and 5hmC in Adaptive and Innate Immune Systems.
Lio CJ; Rao A
Front Immunol; 2019; 10():210. PubMed ID: 30809228
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors upregulate B cell microRNAs that silence AID and Blimp-1 expression for epigenetic modulation of antibody and autoantibody responses.
White CA; Pone EJ; Lam T; Tat C; Hayama KL; Li G; Zan H; Casali P
J Immunol; 2014 Dec; 193(12):5933-50. PubMed ID: 25392531
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of germinal center B and plasma cell fates by dynamical control of IRF4.
Ochiai K; Maienschein-Cline M; Simonetti G; Chen J; Rosenthal R; Brink R; Chong AS; Klein U; Dinner AR; Singh H; Sciammas R
Immunity; 2013 May; 38(5):918-29. PubMed ID: 23684984
[TBL] [Abstract][Full Text] [Related]
11. Roles of TET and TDG in DNA demethylation in proliferating and non-proliferating immune cells.
Onodera A; González-Avalos E; Lio CJ; Georges RO; Bellacosa A; Nakayama T; Rao A
Genome Biol; 2021 Jun; 22(1):186. PubMed ID: 34158086
[TBL] [Abstract][Full Text] [Related]
12. Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.
Putiri EL; Tiedemann RL; Thompson JJ; Liu C; Ho T; Choi JH; Robertson KD
Genome Biol; 2014 Jun; 15(6):R81. PubMed ID: 24958354
[TBL] [Abstract][Full Text] [Related]
13. Regulation of aicda expression and AID activity: relevance to somatic hypermutation and class switch DNA recombination.
Xu Z; Pone EJ; Al-Qahtani A; Park SR; Zan H; Casali P
Crit Rev Immunol; 2007; 27(4):367-97. PubMed ID: 18197815
[TBL] [Abstract][Full Text] [Related]
14. Association of high 5-hydroxymethylcytosine levels with Ten Eleven Translocation 2 overexpression and inflammation in Sjögren's syndrome patients.
Lagos C; Carvajal P; Castro I; Jara D; González S; Aguilera S; Barrera MJ; Quest AFG; Bahamondes V; Molina C; Urzúa U; Hermoso MA; Leyton C; González MJ
Clin Immunol; 2018 Nov; 196():85-96. PubMed ID: 29894742
[TBL] [Abstract][Full Text] [Related]
15. Activation-induced cytidine deaminase alters the subcellular localization of Tet family proteins.
Arioka Y; Watanabe A; Saito K; Yamada Y
PLoS One; 2012; 7(9):e45031. PubMed ID: 23028748
[TBL] [Abstract][Full Text] [Related]
16. TET proteins and 5-methylcytosine oxidation in hematological cancers.
Ko M; An J; Pastor WA; Koralov SB; Rajewsky K; Rao A
Immunol Rev; 2015 Jan; 263(1):6-21. PubMed ID: 25510268
[TBL] [Abstract][Full Text] [Related]
17. B cell Rab7 mediates induction of activation-induced cytidine deaminase expression and class-switching in T-dependent and T-independent antibody responses.
Pone EJ; Lam T; Lou Z; Wang R; Chen Y; Liu D; Edinger AL; Xu Z; Casali P
J Immunol; 2015 Apr; 194(7):3065-78. PubMed ID: 25740947
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms that regulate the activities of TET proteins.
Joshi K; Liu S; Breslin S J P; Zhang J
Cell Mol Life Sci; 2022 Jun; 79(7):363. PubMed ID: 35705880
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic silencing of TET2 and TET3 induces an EMT-like process in melanoma.
Gong F; Guo Y; Niu Y; Jin J; Zhang X; Shi X; Zhang L; Li R; Chen L; Ma RZ
Oncotarget; 2017 Jan; 8(1):315-328. PubMed ID: 27852070
[TBL] [Abstract][Full Text] [Related]
20. [TET proteins and epigenetic modifications in cancers].
Ciesielski P; Jóźwiak P; Krześlak A
Postepy Hig Med Dosw (Online); 2015 Dec; 69():1371-83. PubMed ID: 26671928
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
